FMS logo

FMS Cost of Revenue

Latest reported€14.31B EUR
FMS TTM Cost of Revenue · EUR (€0.00 → €14.31B)
High-resolution chart · PNG

FMS cost of revenue history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) Cost of Revenue — Trailing twelve months (TTM) (EUR)
Period endingCost of Revenue (EUR)
14,307,084,000
14,333,852,000
14,598,673,000
14,731,819,000
14,703,265,000
14,725,913,000
14,579,308,000
14,403,180,000
14,496,102,000
14,524,102,000
14,528,231,000
14,539,282,000
14,684,951,000
14,568,067,000
14,387,582,000
14,066,162,000
13,387,642,000
12,912,703,000
12,541,656,000
12,265,228,000
12,145,675,000
12,252,989,000
12,346,762,000
12,421,639,000
12,440,057,000
12,310,676,000
12,080,704,000
11,874,393,000
11,591,885,000
11,487,236,000
11,392,967,000
11,408,967,000
11,529,933,000
11,596,490,000
11,779,949,000
11,786,798,800
11,662,237,822
11,402,991,182
10,994,504,624
10,685,875,624
10,431,479,833
10,301,600,204
10,316,955,860
10,072,513,220
9,766,067,074
9,102,063,347
8,343,004,815
7,687,923,958
7,312,308,886
7,275,772,588
7,310,009,236
7,246,082,867
7,191,274,217
7,122,537,600
6,917,659,564
7,094,258,873
6,862,319,083
6,476,024,337
6,259,829,106
6,062,006,236
5,968,522,083
6,124,881,881
6,136,026,536
5,947,871,057
5,782,103,364
5,500,097,618
5,351,014,409
5,216,707,292
5,191,695,788
4,992,600,377
4,761,937,729
4,512,530,361
4,346,051,752
4,396,996,812
4,498,192,766
4,458,212,253
4,514,235,364
4,480,827,786
4,294,939,773
4,278,224,525
4,043,652,454
3,817,044,385
3,678,361,027
3,249,122,534
3,166,737,394
3,111,335,851
3,078,950,885
3,063,262,696
3,022,763,571
2,983,231,131
2,997,855,995
3,134,847,554
3,200,133,889
3,249,992,645
3,370,670,927
3,671,997,231
3,686,632,556
3,765,100,597
3,715,388,539
3,562,247,567
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.